About Cardiovate

A Medical Technology Company

How it all began

Cardiovate is a medical technology company that targets transformational health care opportunities in tissue regeneration and repair through the development of novel products that utilize proprietary materials and processes along with a deep understanding of clinical needs. The Cardiovate scaffold promotes the patient’s own cells to organize into a viable tissue after implantation for repair or replacement of damaged and diseased vasculature.

Meet Our Executive Leadership Team

Mark Standeford, PMP, MBA

President & CEO, Director

Medical device development and commercialization experience

Jordan Kaufmann, PhD

CTO & Co-Founder, Director

Developed technology , experienced in university research-based medtech startups

Mark Horsey, MBA

CFO

Startup MedTech Finance and Operations leadership experience

Meet Our Board of Directors

Mauli Agrawal, PhD

Chairman & Co-Founder

Interim Provost and Vice President for Academic Affairs, UTSA

Formed 3 biomedical startup companies in San Antonio.  Former CEO of Xilas Medical 

Steven Bailey, MD

Director, & Co-Founder

Chief, UTHSCSA Interventional Cardiology
Leading interventional Cardiologist and  experienced in medical device startups.

Gary Frashier, MBA, PE

Director

President and CEO of Management Associates

Ashley Hixon, MHA, FACHE

Director

CEO of Xeras Medical Technologies

Former CEO and COO  of  HCA system hospitals

Former Vice President of Cardiovascular Services for Methodist  Healthcare system

Advisors

Gabriele Niederauer, PhD

Advisor

CEO Bluegrass Vascular Technologies

News & Updates

Affiliations

Headquaters

12500 Network Blvd Suite 310
San Antonio, Texas 78249

Research & Development

2500 Crosspark Rd. E-141 Coralville, IA 52241

© Copyright 2017 Cardiovate, Inc. All Rights Reserved.